SEC Filing Summary: Reviv3 Procare Company (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Reviv3 Procare Company (not Axil Brands, Inc.) on August 24, 2023. The report details corporate governance updates approved by the Board of Directors, including the adoption of a new Code of Business Conduct and Ethics and the establishment of three key board committees.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on governance matters and does not contain financial performance data.
Material Changes
- Code of Ethics: The Board approved a new Code of Business Conduct and Ethics to guide officers, directors, and employees in fostering honesty and accountability.
- Board Committees: The Board established the Audit Committee, Nominating and Corporate Governance Committee, and Compensation Committee.
- Leadership Structure: Jeff Toghraie, CEO and Chairman, was initially appointed as the Chairman of all three committees. The Company anticipates filling vacancies on these committees within the next 12 months.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of material risks and contingencies. The primary focus is on the implementation of governance frameworks and the appointment of interim committee leadership.
Key Facts for Investor Verification
- Verify the full text of the newly adopted Code of Business Conduct and Ethics (Exhibit 14.1).
- Review the Charters for the Audit, Nominating, and Compensation Committees (Exhibits 99.1, 99.2, and 99.3).
- Monitor future filings for the appointment of independent directors to fill the committee vacancies currently held by the CEO.
- Confirm the company's current financial status through its most recent 10-K or 10-Q filings, as this 8-K contains no financial data.